Versata Tells Fed Circ. PTAB Overstepped On CBM Review
Versata Development Group Inc. told the Federal Circuit on Wednesday that the Patent Trial and Appeal Board did not have the authority to review its product pricing software patent, let alone...To view the full article, register now.
Already a subscriber? Click here to view full article